Neurophysiologic Maturation Index for Late Preterm Infants
NCT ID: NCT02156817
Last Updated: 2025-10-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
26 participants
OBSERVATIONAL
2014-03-31
2017-06-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Real-time State of Vigilance Monitor for the Neonatal Intensive Care Unit
NCT04920175
Severe Intrauterine Growth Retardation: Developmental Newborn Intensive Care Unit (NICU) Care
NCT00914108
Neurodevelopmental Outcomes of Preterm and Term Children
NCT02309697
Prospective Research in Infants With Mild Encephalopathy
NCT01747863
Prediction of Adverse Outcome Using Fetal MRI in Pregnancies at Risk of Preterm Birth
NCT05164432
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Late Preterm Infants (LPT)
34 weeks and 0-6 days gestational age
Amplitude integrated electroencephalogram, Cardiorespiratory signal acquisition
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Amplitude integrated electroencephalogram, Cardiorespiratory signal acquisition
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admitted to a NICU of a participating institution
* Post-natal age less than 96 hours
Exclusion Criteria
* Growth restriction (birth weight \< 10%, Fenton growth curves)
* Unsure obstetric dating (e.g., absence of a sure LMP without a sonogram, earliest sonogram performed after 20 weeks without a sure LMP, or discrepancy between LMP and sonogram)
* Exposure to medications within the preceding 12 hrs which may affect CNS function (e.g., fentanyl, morphine, midazolam)
* Neonatal seizures
* Neonatal abstinence syndrome secondary to in-utero exposure to narcotics, methadone etc, or at high risk for development of abstinence
* Hypoxia-ischemia defined as the combination of fetal acidemia (cord gas or blood gas within 1 hour of birth: pH ≤ 7.15 or BE ≥ -10mEq/L), need for resuscitation at birth (PPV ± chest compressions or medications), and evidence of encephalopathy (Stage 1, 2 or 3 Sarnat). Stage 1 encephalopathy will be defined based on the level of consciousness which is characterized by a hyper-alert state, apparent alertness, and irritability. In the absence of a cord or early post-natal blood gas, there must be a history of a perinatal event which may have compromised oxygenation or blood flow to the fetus.
* Infants who are expected to be on mechanical (via an endotracheal tube) or high frequency ventilation for the first 96 hours after birth.
* Inability to obtain the informed consent
1 Day
4 Days
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
McGill University Health Centre/Research Institute of the McGill University Health Centre
OTHER
Wayne State University
OTHER
Brown University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Birju A. Shah, MD MPH
Associate Professor of Pediatrics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Birju A Shah, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Brown University - Women and Infants Hospital of Rhode Island
Abbot Laptook, MD
Role: PRINCIPAL_INVESTIGATOR
Brown University - Women and Infants Hospital of Rhode Island
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Wayne State University
Detroit, Michigan, United States
Brown University - Women and Infants Hospital of Rhode Island NICU
Providence, Rhode Island, United States
McGill University Health Center
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Shah BA, Latremouille S, Chawla S, Keszler M, Tucker R, Laptook A, Sant'anna GM. Heart rate variability and amplitude-integrated electroencephalography measured shortly after birth and time to reach clinical milestones: a pilot study in late preterm infants. Front Pediatr. 2025 Jun 5;13:1579197. doi: 10.3389/fped.2025.1579197. eCollection 2025.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13-0052
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.